MARION CURTIS: Open Payments
NPI 1841771011 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 8 payments from 6 companies in 2025. Trend: 2023 $650 · 2024 $320 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 1 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: SPRAVATO, Qelbree, ABILIFY ASIMTUFII, COBENFY, REXULTI, CAPLYTA, TRINTELLIX.
Industry payments across GA — which companies pay providers there.
